Kidney, patient and new millennium nephrology

Area of Science:

• Nephrology and renal medicine.
• Biotechnology and biomedical engineering.
• Medical ethics and healthcare management.

Background:

• The practice of nephrology is evolving due to shifts in clinical environments and the need for basic research to find clinical applications.
• Nephrologists will face increasing involvement in managing renal substitution therapy, including treatment and cost.
• Advancements in molecular biology offer significant potential for treating acquired and hereditary renal diseases.

Purpose of the Study:

• To outline the anticipated developments and challenges in nephrology for the new millennium.
• To explore the integration of molecular biology, gene therapy, and artificial substitution therapies.
• To envision the future of renal transplantation, focusing on donor supply, immunomodulation, and diagnostics.

Main Methods:

• Review of current trends and future projections in nephrology.
• Exploration of potential applications of molecular biology and gene therapy in renal disease.
• Conceptualization of advanced dialysis technologies and transplantation strategies.

Main Results:

• Expectations for molecular biology to drive advancements in nephropathology, including gene therapy.
• Development of 'intelligent dialysis' combining biological and diagnostic components for personalized treatment.
• Ideal renal transplantation scenarios include matching donor supply (e.g., xenotransplantation), perfected immunomodulation, and real-time biomolecular diagnostics.

Conclusions:

• The future of nephrology hinges on integrating technological advancements and personalized medicine.
• Molecular biology and innovative therapeutic strategies like gene therapy and intelligent dialysis will reshape renal care.
• Optimizing renal transplantation requires addressing donor shortages and enhancing diagnostic precision through biomolecular insights.